Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy

Journal of Cellular Physiology

Volumn 227, Issue 10, 2012, Pages 3471-3476

  Di Domenico, Marina ^a   Casadonte, Rita ^b   Ricci, Pietroantonio ^b   Santini, Mario ^a   Frati, Giacomo ^c   Rizzo, Antonietta ^a   Carratelli, Caterina Romano ^a   Lamberti, Monica ^a   Parrotta, Elvira ^b   Quaresima, Barbara ^b   Faniello, Concetta M ^b   Costanzo, Francesco ^b   Cuda, Giovanni ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN BETA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; GENE EXPRESSION; GENETIC HETEROGENEITY; HEART MUSCLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TWITCH; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; WESTERN BLOTTING;

ACTINS; ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUTATION; MYOCARDIUM; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; RNA, MESSENGER; VENTRICULAR MYOSINS; YOUNG ADULT;

EID: 84862676510     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24047     Document Type: Article

References (33)

1. Arad M, Seidman JG, Seidman CE. 2002. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 11: 2499- 2506.
2. Atiga WL, Fananapazir L, McAreavey D, Calkins H, Berger RD. 2000. Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations. Circulation 101: 1237- 1242.
3. Charron P, Dubourg O, Desnos M, Bennaceur M, Carrier L, Camproux AC, Isnards R, Hagege Langlards JM, Bonne G, Richard P, Hainque B, Bouhour JB, Schwartz K, Komajda M. 1998. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 97: 2230- 2236.
4. Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K, Watkins H. 2003. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41: 1776- 1782.
5. Cuda G, Fananapazir L, Zhu WS, Sellers JR, Epstein ND. 1993. Skeletal muscle expression and abnormal function of beta myosin in hypertrophic cardiomyopathy. J Clin Invest 91: 2861- 2865.
6. Cuda G, Perrotti N, Perticone F, Mattioli PL. 1996. A previously undescribed de novo insertion-deletion mutation in the beta-myosin heavy chain gene in an italian kindred with familial hypertrophic cardiomyopathy. Heart 76: 451- 452.
7. Cuda G, Fananapazir L, Epstein ND, Sellers JR. 1997. The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil 18: 275- 283.
8. Eisemberg E, Kielley WW. 1974. Troponin-tropomyosin complex. J Biol Chem 249: 4742- 4748.
9. Ghosh N, Haddad H. 2011. Recent progress in the genetics of cardiomyopathy and its role in the clinical evaluation of patients with cardiomyopathy. Curr Opin Cardiol 26: 155- 164.
10. Horowits R, Kempner ES, Bisher ME, Podolsky RJ. 1986. A physiological role for titin and nebulin in skeletal muscle. Nature 323: 160- 164.
11. Jaenicke T, Diederich KW, Haas W, Schleich J, Lichter P, Pfordt M, Bach A, Vosberg HP. 1990. The complete sequence of the human β-myosin heavy chain gene and a comparative analysis of its product. Genomics 8: 194- 206.
12. Keren A, Syrris P, McKenna WJ. 2008. Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 5: 158- 168.
13. Malinchik S, Cuda G, Podolsky RJ, Horowits R. 1997. Isometric tension and mutant myosin heavy chain content in single skeletal myofibers from hypertrophic cardiomyopathy patients. J Mol Cell Cardiol 29: 667- 676.
14. Maron BJ. 2002. Hypertrophic cardiomyopathy: A systematic review. JAMA 287: 1308- 1320.
15. Maron BJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Epstein SE. 1976. Asymmetric septal hypertrophy in childhood. Circulation 53: 9- 19.
16. Maron BJ, Roberts WC, Edwards JE, McAllister HA, Jr, Foley DD, Epstein SE. 1978. Sudden death in patients with hypertrophic cardiomyopathy: Characterization of 26 patients without functional limitation. Am J Cardiol 41: 803- 810.
17. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. 1987. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316: 780- 789, 844-852.
18. Maron BJ, Moller JH, Seidman CE, Vincent GM, Dietz HC, Moss AJ, Sondheimer HM, Pyeritz RE, McGee G, Epstein AE. 1998. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. Circulation 98: 1460- 1471.
19. Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H. 2009. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 105: 219- 222.
20. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H. 1997. Sudden death due to troponin T mutations. J Am Coll Cardiol 29: 549- 555.
21. Nier V, Schultz I, Brenner B, Forssmann W, Raida M. 1999. Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein. FEBS Lett 461: 246- 252.
22. Seidman JG, Seidman C. 2001. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell 104: 557- 567.
23. Shah AM, Mebazaa A, Yang Z-K, Cuda G, Lankford EB, Pepper CB, Sollott SJ, Sellers JR, Robotham JL, Lakatta EG. 1997. Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells. A potential mechanism for matching oxygen supply and demand? Circ Res 80: 688- 698.
24. Spirito P, Chiarella F, Carratino L, Berisso M, Bellotti P, Vecchio C. 1989. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 320: 749- 755.
25. Spirito P, Seidman CE, McKenna WJ, Maron BJ. 1997. The management of hypertrophic cardiomyopathy. N Engl J Med 336: 775- 785.
26. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. 2000. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342: 1778- 1785.
27. Teare D. 1958. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20: 1- 18.
28. Tysca MJ, Hayes M, Giewat CE, Seidman CE, Seidman JG, Warshaw DM. 2000. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res 86: 737- 744.
29. Watkins H, Rosenzweig A, Hwang D-S, Levi T, McKenna W, Seidman CE, Seidman JG. 1992. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326: 1108- 1114.
30. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. 1995. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058- 1064.
31. Watkins H, Ashrafian H, Redwood C. 2011. Inherited cardiomyopathies. N Engl J Med 364: 1643- 1656.
32. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. 1985. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 28: 1- 83.
33. Wigle ED, Rakowski H, Kimball BP, Williams WG. 1995. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92: 1680- 1692.